100 related articles for article (PubMed ID: 16973920)
21. Development of a scintillation proximity assay for human insulin-like growth factor-binding protein 4 compatible with inhibitor high-throughput screening.
Khawaja XZ
Anal Biochem; 2007 Jul; 366(1):80-6. PubMed ID: 17482135
[TBL] [Abstract][Full Text] [Related]
22. Computational Sampling and Simulation Based Assessment of Novel Mycobacterium tuberculosis Glutamine Synthetase Inhibitors: Study Involving Structure Based Drug Design and Free Energy Perturbation.
Suryadevara P; Yogeeswari P; Soni V; Devi PB; Nandicoori VK; Sriram D
Curr Top Med Chem; 2016; 16(9):978-95. PubMed ID: 26303425
[TBL] [Abstract][Full Text] [Related]
23. Image-based screening for the identification of novel proteasome inhibitors.
Rickardson L; Wickström M; Larsson R; Lövborg H
J Biomol Screen; 2007 Mar; 12(2):203-10. PubMed ID: 17208922
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the amino acid binding site of Mycobacterium tuberculosis glutamine synthetase for drug discovery.
Nordqvist A; Nilsson MT; Röttger S; Odell LR; Krajewski WW; Evalena Andersson C; Larhed M; Mowbray SL; Karlén A
Bioorg Med Chem; 2008 May; 16(10):5501-13. PubMed ID: 18462943
[TBL] [Abstract][Full Text] [Related]
25. A novel high-throughput screening format to identify inhibitors of secreted acid sphingomyelinase.
Mintzer RJ; Appell KC; Cole A; Johns A; Pagila R; Polokoff MA; Tabas I; Snider RM; Meurer-Ogden JA
J Biomol Screen; 2005 Apr; 10(3):225-34. PubMed ID: 15809318
[TBL] [Abstract][Full Text] [Related]
26. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets.
Harth G; Horwitz MA
J Exp Med; 1999 May; 189(9):1425-36. PubMed ID: 10224282
[TBL] [Abstract][Full Text] [Related]
27. [Methionine sulfoximine and phosphinothricin--glutamine synthetase inhibitors and activators and their herbicidal activity (A review)].
Evstigneeva ZG; Solov'eva NA; Sidel'nikova LI
Prikl Biokhim Mikrobiol; 2003; 39(6):613-8. PubMed ID: 14714472
[TBL] [Abstract][Full Text] [Related]
28. High-throughput screening of enzyme inhibition using an inhibitor gradient generated in a microchannel.
Garcia E; Hasenbank MS; Finlayson B; Yager P
Lab Chip; 2007 Feb; 7(2):249-55. PubMed ID: 17268628
[TBL] [Abstract][Full Text] [Related]
29. A coupled assay measuring Mycobacterium tuberculosis antigen 85C enzymatic activity.
Boucau J; Sanki AK; Voss BJ; Sucheck SJ; Ronning DR
Anal Biochem; 2009 Feb; 385(1):120-7. PubMed ID: 18992216
[TBL] [Abstract][Full Text] [Related]
30. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
[TBL] [Abstract][Full Text] [Related]
31. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists.
Zhang R; Yan PK; Zhou CH; Liao JY; Wang MW
Acta Pharmacol Sin; 2007 Jan; 28(1):125-31. PubMed ID: 17184592
[TBL] [Abstract][Full Text] [Related]
32. Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform.
Theron A; Roth RL; Hoppe H; Parkinson C; van der Westhuyzen CW; Stoychev S; Wiid I; Pietersen RD; Baker B; Kenyon CP
PLoS One; 2017; 12(10):e0185068. PubMed ID: 28972974
[TBL] [Abstract][Full Text] [Related]
33. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry.
Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC
Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069
[TBL] [Abstract][Full Text] [Related]
34. Hexokinase inhibitor screening based on adenosine 5'-diphosphate determination by electrophoretically mediated microanalysis.
Wang T; Kang J
Electrophoresis; 2009 Apr; 30(8):1349-54. PubMed ID: 19306267
[TBL] [Abstract][Full Text] [Related]
35. On-bead combinatorial techniques for the identification of selective aldose reductase inhibitors.
Robins LI; Dixon SM; Wilson DK; Kurth MJ
Bioorg Med Chem; 2006 Dec; 14(23):7728-35. PubMed ID: 16931029
[TBL] [Abstract][Full Text] [Related]
36. Microtiter plate based chemistry and in situ screening: a useful approach for rapid inhibitor discovery.
Brik A; Wu CY; Wong CH
Org Biomol Chem; 2006 Apr; 4(8):1446-57. PubMed ID: 16604207
[TBL] [Abstract][Full Text] [Related]
37. Development of a high-throughput scintillation proximity assay for the identification of C-domain translational initiation factor 2 inhibitors.
Delle Fratte S; Piubelli C; Domenici E
J Biomol Screen; 2002 Dec; 7(6):541-6. PubMed ID: 14599352
[TBL] [Abstract][Full Text] [Related]
38. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
[TBL] [Abstract][Full Text] [Related]
39. [High throughput screening method of nitric oxide synthase inhibitors and enhancers].
Sun ME; Chen YH; Du GH
Yao Xue Xue Bao; 2002 Mar; 37(3):161-4. PubMed ID: 12579752
[TBL] [Abstract][Full Text] [Related]
40. New high-throughput fluorimetric assay for discovering inhibitors of UDP-N-acetylmuramyl-L-alanine: D-glutamate (MurD) ligase.
Kristan K; Kotnik M; Oblak M; Urleb U
J Biomol Screen; 2009 Apr; 14(4):412-8. PubMed ID: 19403924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
